Literature DB >> 2492322

Limited usefulness of intermittent nitroglycerin patches in stable angina.

D D Waters1, M Juneau, D Gossard, G Choquette, M Brien.   

Abstract

The efficacy of continuous and intermittent nitroglycerin patches (10 mg/day) was compared in a randomized, placebo-controlled trial in 36 patients with stable angina and reproducible, exercise-induced ST depression. Intermittent treatment was administered either 18 or 14 h/day with an intermission of 6 h or 10 h, respectively. Exercise tests were performed during the last 2 h of patch application. Compared with placebo, neither continuous nitroglycerin nor the two intermittent regimens prolonged total treadmill time or time to 1 mm ST depression. No treatment eliminated exercise-induced ST depression in greater than 1 of the 36 patients. Time to angina was prolonged (by 40 +/- 66 s) only during the "10 h off" treatment (p = 0.001); time to angina increased by greater than or equal to 20% in 13 patients. Responders to treatment could be predicted by a short history of angina (p less than 0.05) and a time to angina less than or equal to 250 s during the placebo test. For each treatment, greater than or equal to 25 of the patients reported headache; 4 additional patients dropped out because of severe headache and 2 others because of a coronary event in a washout period. Thus, in most patients with stable angina, side effects outweight any benefit demonstrable with this therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492322     DOI: 10.1016/0735-1097(89)90521-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate.

Authors:  M A James; M Papouchado; J V Jones
Journal:  Br Heart J       Date:  1992-05

Review 2.  An update on nitrate tolerance: can it be avoided?

Authors:  S R Maxwell; M J Kendall
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

Review 3.  Transdermal nitroglycerin. Does it really work in the treatment of angina?

Authors:  A Fletcher
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

Review 4.  Intermittent or continuous transdermal nitroglycerin: still an issue, or is the case closed?

Authors:  T O Klemsdal; K Gjesdal
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

Review 5.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  [Not Available].

Authors:  D Gossard; J C Tardif
Journal:  Can Fam Physician       Date:  1991-03       Impact factor: 3.275

Review 7.  Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.

Authors:  P A Todd; K L Goa; H D Langtry
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

8.  Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.

Authors:  D R Holdright; R J Katz; C A Wright; J L Sparrow; A K Sullivan; A D Cunningham; K M Fox
Journal:  Br Heart J       Date:  1993-03

9.  Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.

Authors:  K M Fox; H J Dargie; J Deanfield; A Maseri
Journal:  Br Heart J       Date:  1991-08

Review 10.  Ointments and transdermal nitroglycerin patches for stable angina pectoris.

Authors:  U Thadani; R J Lipicky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.